Skip to main content

Thomas Anthony D'Amico, MD

Gary Hock Distinguished Professor of Surgery
Director, Integrated Thoracic Surgery Residency Program and Joint General Surgery and Thoracic Surgery Residency Program
Director, Advanced Training in Cardiothoracic Surgery
Professor of Surgery
Office: Duke South - 3589 White Zone, Durham, NC 27710
Campus Mail: DUMC Box 3496 Med Ctr, Durham, NC 27710

Lung Cancer

1.Role of molecular markers in the prognosis and therapy of lung cancer
2.Genomic analysis lung cancer mutations

Esophageal Cancer

1.Role of molecular markers in the prognosis and therapy of esophageal cancer
2.Genomic analysis esophageal cancer mutations

Education and Training

  • M.D., Columbia University, 1987

Publications

Esophageal Cancer Study Group Participating Centers, S. M. “Predictors of staging accuracy, pathologic nodal involvement, and overall survival for cT2N0 carcinoma of the esophagus.” J Thorac Cardiovasc Surg 157, no. 3 (March 2019): 1264-1272.e6. https://doi.org/10.1016/j.jtcvs.2018.10.057.

Full Text

Yang, Chi-Fu Jeffrey, Arvind Kumar, Jacob A. Klapper, Matthew G. Hartwig, Betty C. Tong, David H. Harpole, Mark F. Berry, and Thomas A. D’Amico. “A National Analysis of Long-term Survival Following Thoracoscopic Versus Open Lobectomy for Stage I Non-small-cell Lung Cancer.” Ann Surg 269, no. 1 (January 2019): 163–71. https://doi.org/10.1097/SLA.0000000000002342.

Full Text

Hennon, Mark W., Abbinav Kumar, Harshita Devisetty, Thomas D’Amico, Todd L. Demmy, Adrienne Groman, and Sai Yendamuri. “Minimally Invasive Approaches Do Not Compromise Outcomes for Pneumonectomy: A Comparison Using the National Cancer Database.” J Thorac Oncol 14, no. 1 (January 2019): 107–14. https://doi.org/10.1016/j.jtho.2018.09.024.

Full Text

Moffatt-Bruce, Susan D., Thomas A. D’Amico, Richard D. Weisel, and Robert M. Sade. “The Aggressive Cholesterol Therapy to Inhibit Vein Graft Events trial: To continue or not? How to answer the question.” J Thorac Cardiovasc Surg 157, no. 1 (January 2019): 164–65. https://doi.org/10.1016/j.jtcvs.2018.09.066.

Full Text

Schieman, Colin, Christopher W. Seder, Thomas A. D’Amico, and Sean C. Grondin. “General thoracic surgical training in North America: Contrasting general thoracic surgery residencies in Canada and the United States.” J Thorac Cardiovasc Surg 156, no. 6 (December 2018): 2379–87. https://doi.org/10.1016/j.jtcvs.2018.07.016.

Full Text

Yang, Chi-Fu Jeffrey, Derek Y. Chan, Shivani A. Shah, Babatunde A. Yerokun, Xiaofei F. Wang, Thomas A. D’Amico, Mark F. Berry, and David H. Harpole. “Long-term Survival After Surgery Compared With Concurrent Chemoradiation for Node-negative Small Cell Lung Cancer.” Ann Surg 268, no. 6 (December 2018): 1105–12. https://doi.org/10.1097/SLA.0000000000002287.

Full Text

Shen, Yaxing, Jianfei Shen, Kevin Phan, David Tian, Thomas A. D’Amico, Mark F. Berry, Shanda H. Blackmon, et al. “A young man with progressive esophageal neoplasms.” J Thorac Dis 10, no. 11 (November 2018): 5985–90. https://doi.org/10.21037/jtd.2018.10.56.

Full Text

Mulvihill, Michael S., Morgan L. Cox, David C. Becerra, Joshua A. Watson, Soraya L. Voigt, Babatunde A. Yerokun, Paul J. Speicher, Thomas A. D’Amico, Betty Tong, and Matthew G. Hartwig. “Higher Use of Surgery Confers Superior Survival in Stage I Non-Small Cell Lung Cancer.” Ann Thorac Surg 106, no. 5 (November 2018): 1533–40. https://doi.org/10.1016/j.athoracsur.2018.05.066.

Full Text

Ackerson, Bradley G., Betty C. Tong, Julian C. Hong, Lin Gu, Junzo Chino, Jacob W. Trotter, Thomas A. D’Amico, et al. “Stereotactic body radiation therapy versus sublobar resection for stage I NSCLC.” Lung Cancer 125 (November 2018): 185–91. https://doi.org/10.1016/j.lungcan.2018.09.020.

Full Text

Hirji, Sameer A., and Thomas A. D’Amico. “Visiting an old foe: distant recurrence following R0 lobectomy for pathological N0 lung adenocarcinoma.” J Thorac Dis 10, no. Suppl 26 (September 2018): S3286–89. https://doi.org/10.21037/jtd.2018.08.116.

Full Text

Pages